Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 1/2018

Ausgabe 1/2018

Inhaltsverzeichnis ( 19 Artikel )

27.02.2018 | Onkologie | editorial | Ausgabe 1/2018

Revival of anti-angiogenic therapies in cancer

News from an old therapeutic concept—part 2
Andreas Pircher MD PhD

23.02.2018 | Onkologie | editorial | Ausgabe 1/2018

Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes

Ursula M. Vogl MD

02.03.2018 | editorial | Ausgabe 1/2018

In need of special care: adolescent and young adult patients with cancer

Assoc. Prof. Michael N. Dworzak M.D., Ph.D.

05.01.2018 | editorial | Ausgabe 1/2018

memo—publisher’s report 2017

Alois Sillaber

23.02.2018 | short review | Ausgabe 1/2018

Targeting angiogenesis in lung cancer

Sameh Daher MD, Jair Bar MD, PhD

02.02.2018 | short review | Ausgabe 1/2018 Open Access

Anti-angiogenic therapies in brain metastases

Anna S. Berghoff MD, PhD, Matthias Preusser MD

23.02.2018 | short review | Ausgabe 1/2018

Antiangiogenic therapies in ovarian cancer

Adriaan Vanderstichele MD, Siel Olbrecht MD, Ignace Vergote MD PhD

22.12.2017 | review | Ausgabe 1/2018 Open Access

My burning issues in the neoadjuvant treatment for breast cancer

Elisabeth S. Bergen, Rupert Bartsch

21.12.2017 | editorial | Ausgabe 1/2018

My burning issues in TKI therapy and treatment-free remission in CML

Dominik Wolf MD

21.02.2018 | short review | Ausgabe 1/2018

Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer

PD Dr. med. univ. Peter Horak PhD

08.01.2018 | case report | Ausgabe 1/2018

Local therapy of stage IV renal cell cancer: a case report

Muna Ferner, Andrea Vera Keck, Dora Niedersüß-Beke, Kathrin Strasser-Weippl

08.03.2018 | short review | Ausgabe 1/2018 Open Access

PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients

Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Irene Resch, Shahrokh F. Shariat, Kilian M. Gust

02.08.2017 | review | Ausgabe 1/2018

Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia

Characteristics and treatment outcome
Mirella Ampatzidou M.D., Charikleia Kelaidi, Michael N. Dworzak, Sophia Polychronopoulou

21.02.2018 | review | Ausgabe 1/2018

Novel guidelines on surveillance for breast cancer, cardiomyopathy, male gonadotoxicity, and premature ovarian insufficiency from the PanCare and International Guideline Harmonization Group on long-term follow-up after cancer in childhood

Edit Bardi MD, Ph.D, Assoc. Prof. Leo Kager MD

21.02.2018 | short review | Ausgabe 1/2018 Open Access

Short overview on the current standard of treatment in newly diagnosed multiple myeloma

Dr. med. Ella Willenbacher, Dr. med. Agnes Balog, Dr. med. Wolfgang Willenbacher

20.09.2017 | review | Ausgabe 1/2018

Cell free nucleic acids as diagnostic and prognostic marker in leukemia

Maryam Eini, Seyed Ali Nojoumi, Mohammad-Amin Saki, Abbas Khosravi

21.02.2018 | case report | Ausgabe 1/2018 Open Access

Pleural effusion in 11:14 translocation q1 multiple myeloma in the setting of proteasome inhibitor presents therapeutic complexity

Malik Ghannam MBBCh, Maria Bryan MS, Erik Kuross DO, Brent Berry MD/PhD

16.02.2018 | comment | Ausgabe 1/2018 Open Access

ESMO 2017—my personal highlights

Barbara Kiesewetter M.D., Mircea Dediu M.D., Rupert Bartsch M.D.

21.02.2018 | Publisher Correction | Ausgabe 1/2018

Correction to: Report from the WCLC 2017 Congress, Yokohama, 15th–18th October, 2017

Springer-Verlag GmbH Austria

Aktuelle Ausgaben